About Day One Biopharmaceuticals, Inc. Common Stock
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
Market Cap
$0.82B
Employees
181
Listed Since
May 27, 2021
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.dayonebio.comPhone
650 484-0899
Headquarters
2000 SIERRA POINT PARKWAY, SUITE 501
BRISBANE, CA 94005
CIK
0001845337